DNA methylation and gene silencing in cancer
- 1 December 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Oncology
- Vol. 2 (S1), S4-S11
- https://doi.org/10.1038/ncponc0354
Abstract
Nature Clinical Practice Oncology will deliver timely interpretations of key research developments, translating the latest findings into clinical practice. Our Editor-in-Chief and international Advisory Board will ensure comprehensive coverage of topical issues throughout the year, with the highest standards of editorial quality and integrity that are hallmarks of Nature Publishing Group.Keywords
This publication has 43 references indexed in Scilit:
- CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTSAnnual Review of Pharmacology and Toxicology, 2005
- Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumorsNature Genetics, 2003
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002
- DNA methylation patterns and epigenetic memoryGenes & Development, 2002
- Targeting Hypomethylation of DNA to Achieve Cellular Differentiation in Myelodysplastic Syndromes (MDS)The Oncologist, 2001
- Transitions in Distinct Histone H3 Methylation Patterns at the Heterochromatin Domain BoundariesScience, 2001
- Translating the Histone CodeScience, 2001
- Dnmt3a and Dnmt3b Are Transcriptional Repressors That Exhibit Unique Localization Properties to HeterochromatinOnline Journal of Public Health Informatics, 2001
- Hypermethylation of tumor suppressor genes in cancerSeminars in Cancer Biology, 1999
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences of the United States of America, 1998